Feasibility and safety of passive cooling in a cohort of asphyxiated newborn infants

University Children's Hospital of Berne, Inselspital, Switzerland
Schweizerische medizinische Wochenschrift (Impact Factor: 2.09). 03/2013; 143. DOI: 10.4414/smw.2013.13767
Source: PubMed


Therapeutic hypothermia has become a standard neuroprotective treatment in term newborn infants following perinatal asphyxia. Active cooling with whole body surface or head cooling is complex, expensive and often associated with initial hypothermic overshoot. We speculated that passive cooling might suffice to induce and maintain hypothermia.
We analysed 18 asphyxiated term newborns treated with hypothermia in three tertiary neonatal and paediatric intensive care units. Target temperatures of 33.5 °C or 33.0 °C were induced and maintained by turning off the heating system of the open neonatal care unit and by using analgesics and sedatives. We compared our results with matching published data from the hypothermia trial of the National Institute of Child Health and Human Development (NICHD) neonatal research network.
Four infants required no active cooling at all during the whole cooling period. The other 14 infants had passive cooling during 85% of the total cooling time, and active cooling with ice packs in 15% of the total cooling time. Overshoot was smaller in the present study than in the NICHD study.
Passive cooling for asphyxiated newborns appears to be feasible for induction and maintenance of hypothermia with a lower risk of overshoot.

Full-text preview

Available from:
  • [Show abstract] [Hide abstract] ABSTRACT: Hintergrund Risikofaktoren, welche zu Unterkühlungen oder Hitzekrankheiten führen können, bleiben im klinischen Alltag häufig unbeachtet und führen zu vermeidbarer Morbidität. Dies gilt für postnatale oder perioperative Hypothermie oder für Hyperthermie bei Adoleszenten im Spitzensport, bei Dehydratation oder beim „drug fever“. Behandlung Zur Therapie gehört nicht nur die Wiederherstellung der Normothermie, sondern auch die Korrektur pathophysiologischer Entgleisungen v. a. bei Hypothermie mit Scheintod und beim Hitzschlag mit „multiple organ dysfunction syndrome“. Hypo- und Hyperthermie treten auch im Rahmen diverser Grundleiden auf, wobei sich die Frage nach der anzustrebenden Körpertemperatur stellt. Normothermie erscheint sinnvoll in Situationen, in welchen abnorme Körpertemperatur mit Morbidität assoziiert ist, z. B. bei Hypothermie im Rahmen von Sepsis, Trauma oder schwerer Herzinsuffizienz und bei Hyperthermie nach perinataler Asphyxie, Hirnschlag, Hirnblutung oder Schädel-Hirn-Trauma. Abnorme Körpertemperaturen können bei gewissen Erkrankungen aber auch zur Verbesserung des Behandungsergebnisses beitragen, wie Fieber im Infekt oder therapeutische Hypothermie als Standardtherapie nach perinataler Asphyxie oder Herz-Kreislauf-Stillstand.
    No preview · Article · Mar 2013 · Monatsschrift Kinderheilkunde
  • [Show abstract] [Hide abstract] ABSTRACT: Abstract A systematic review and meta-analysis were performed to determine the effect of therapeutic hypothermia using low-technology methods, in settings with facilities for intensive care, in term or near-term infants with hypoxic-ischaemic encephalopathy on mortality, neurological morbidity at discharge and neurological morbidity at 6-24 months. CONCLUSION: Meta-analysis of three randomised controlled studies showed that low-technology therapeutic hypothermia in an intensive care setting significantly reduced the mortality and the neurological morbidity in survivors at discharge.
    No preview · Article · Oct 2014 · Acta paediatrica
  • [Show abstract] [Hide abstract] ABSTRACT: The focus of this review is to collate the literature on the phenomenon of impaired thermal adaptation after hypoxic ischaemic (HI) delivery often culminating in hypothermia. This phenomenon appears different in severity and duration to a spontaneous postnatal fall in temperature observed after normal delivery. The original observation and contemporary descriptions of the temperature response to HI are described and a mechanism of action is proposed that may be utilised as a novel biomarker for HI. © 2015 S. Karger AG, Basel.
    No preview · Article · Feb 2015 · Neonatology
Show more